vimarsana.com
Home
Live Updates
Tarsus Strengthens Financial Position and Refinances Existin
Tarsus Strengthens Financial Position and Refinances Existin
Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon
IRVINE, Calif., April 23, 2024 -- Tarsus Pharmaceuticals, Inc. , whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients,...
Related Keywords
United States ,
David Nakasone ,
Adrienne Kemp ,
Tarsus Pharmaceuticals Inc ,
Nasdaq ,
Corporate Communications ,
Exchange Commission ,
Pharmakon Advisors ,
Maturity Date ,
Biopharma Credit ,
Tarsus Pharmaceuticals ,
Meibomian Gland Disease ,
Tarsu Form ,
Markets ,